[The presence and significance of HBe antigens and anti-HBe antibodies in HBs antigen positive patients]. 1981

V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki

There have been examined 105 sera of HBeantigen carriers, 30 of patients with chronic persistent hepatitis, 17 of patients with active hepatitis and 30 of HBeantigen-positive patients on chronic hemodialysis) for the presence of HBeantigen and antiHBe antibodies. A high percentage of HBeantigens was found in patients with chronic active hepatitis (88,2%) as well as in patients on chronic hemodialysis (86,7%) while the finding of antiHBeantigen in these two groups was low, 11,8% and 3,3%, respectively. The presence of HBeantigen in other two groups was lower, 26,7% in patients with chronic persistent hepatitis and 28,5% in patients with asymptomatic HBe antigenemia. AntiHBe antibodies were present in a higher percentage in patients with chronic persistent hepatitis (70%) than in asymptomatic HBeantigen carriers (57,1%). The presence of HBeantigens is not always sign of severe liver function disorder as well as the presence of anti HBe antibodies is not always sign of preserved liver function.

UI MeSH Term Description Entries
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki
January 1986, Virologie,
V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki
August 1980, Deutsche medizinische Wochenschrift (1946),
V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki
August 1983, Schweizerische medizinische Wochenschrift,
V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki
June 1979, Nihon rinsho. Japanese journal of clinical medicine,
V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki
September 1987, The American journal of gastroenterology,
V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki
January 1978, Archivum immunologiae et therapiae experimentalis,
V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki
June 1986, Rinsho byori. The Japanese journal of clinical pathology,
V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki
January 1979, Acta clinica Belgica,
V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki
January 2004, Hepato-gastroenterology,
V Zivanović-Marinković, and R Kaljalović, and V Marinković, and B Dumović, and A Lazarov, and N Nanusević, and L Krstić, and S Parabucki
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Copied contents to your clipboard!